[ ] How Have Clinical Trials Changed in Chronic Lymphocytic Leukemia?

Published on

Topics include: Treatments

John Gribben, MD, DSc, FRCPath, FMed Sci from Bart's Cancer Institute, London, discusses how Chronic Lymphocytic Leukemia (CLL) clinical trials have changed over time. Today, trials involve treatments that are known to be beneficial to patients and novel agents tend to be trialled in combination to improve patient response whilst not increasing toxicity. Recorded at the 2016 American Society of Hematology (ASH) Annual Meeting, held in San Diego, CA.

This program has been supported by AbbVie through an unrestricted grant to the Patient Empowerment Foundation.

View more programs featuring

Related Programs


Join Our Community Register for Events Read Our Latest Blog

Page last updated on January 26, 2017